Proventil Hfa
NDC Package 0085-1132-02

11-digit billing NDC: 00085113202
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Proventil Hfa is pROVENTIL® HFA Inhalation Aerosol is indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. Marketed by Merck Sharp & Dohme Corp., this product is identified by NDC 0085-1132 and is authorized under FDA application NDA020503.

Identification & Billing

NDC Package Code
0085-1132-02
Package Description
1 CANISTER in 1 CARTON / 100 AEROSOL, METERED in 1 CANISTER
Product Code
0085-1132
11-Digit Billing Format
00085113202
RxNorm Crosswalk
  • RxCUI: 2123111 - albuterol 90 MCG/INHAL Metered Dose Inhaler, 200 Actuations, generic for Proventil
  • RxCUI: 2123111 - NDA020503 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler
  • RxCUI: 746763 - Proventil HFA 90 MCG/INHAL Metered Dose Inhaler, 200 Actuations
  • RxCUI: 746763 - NDA020503 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler [Proventil]
  • RxCUI: 746763 - NDA020503 200 ACTUAT Proventil 0.09 MG/ACTUAT Metered Dose Inhaler

Clinical Specifications

Proprietary Name
Proventil Hfa
Dosage Form
-
Usage Information
PROVENTIL® HFA Inhalation Aerosol is indicated in adults and children 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

Regulatory & Marketing

Labeler Name
Merck Sharp & Dohme Corp.
FDA Application #
NDA020503
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-2001
Listing Expiration
12-31-2020
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0085-1132). Click a package code to view its specific billing and regulatory data.

0085-1132-01
1 CANISTER in 1 CARTON / 200 AEROSOL, METERED in 1 CANISTER
0085-1132-04
1 CANISTER in 1 CARTON / 200 AEROSOL, METERED in 1 CANISTER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0085-1132-02 identifies a specific commercial package of 1 canister in 1 carton / 100 aerosol, metered in 1 canister of Proventil Hfa, labeled by Merck Sharp & Dohme Corp.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Merck Sharp & Dohme Corp. on October 01, 2001. The current certification is valid through December 31, 2020.

How is this Merck Sharp & Dohme Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00085113202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0085-1132-02
11-Digit CMS (5-4-2)
00085-1132-02

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.